| |
| HEALTHCARE |
Ebola: AHF Africa Urges WHO to Accelerate Response; Faults African Union’s Silence
January 16, 2019
(AETOS Wire) -- AIDS Healthcare Foundation (AHF), the largest global AIDS organization operating in 43 countries, is profoundly concerned with the rise in new Ebola cases in the Democratic Republic of Congo and fear of its spread if uncontained. The August 1, 2018 outbreak is now the second deadliest in history and seems to be spiralling out of control amid insecurity in the country. This follows after the devastating 2014 outbreak which claimed over 11,000 lives in West Africa, including two of AHF’s doctors. As of Jan 2, 2019, the total number of confirmed and probable patients is estimated to have surpassed 600, with 368 deaths and 207 people who have recovered from the illness, according to CNN. With the epicentre of the outbreak bordering Uganda and Rwanda, there is a “high risk” of it extending, particularly due to the country experiencing insecurity issues. These......
Chronic life-saving medicines in short supply in Sudan
January 14, 2019
The former head of the Private Pharmacies Association, Dr Nasri Morgos, has reported a scarcity of medicines in Sudan. The ongoing shortage of foreign currency in the country means that especially life-saving chronic medicines and permanent eye drops are running short. For the few medicines still available, Dr Morgos predicted further prices rises of about 400 per cent and predicted “a disaster” in the near future. “The"...
Duk Pagak county commissioner decries lack of medicines
January 9, 2019
The commissioner of Duk Pagak County in South Sudan’s Jonglei state, Yien Jal has decried the unavailability of life-saving medicines in the county since December last year. Speaking to Radio Tamazuj on Friday, Jal said local residents have not been accessing basic health services after the only health facility ran out of drugs. “Now it is almost two weeks"...
ResMed Completes $225 Million Acquisition of Propeller Health
January 9, 2019
(AETOS Wire)-- ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and asthma. This press release features multimedia."...
Takeda Completes Acquisition of Shire, Becoming a Global, Values-Based, R&D-Driven Biopharmaceutical Leader
January 9, 2019
- 8 months from deal announcement to deal close
- Strong shareholder support with high approval rates on Takeda (89.1%) and Shire (99.8%)
- Integration planning well underway
(AETOS Wire)-- Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced the completion of its acquisition of Shire plc (“Shire”), becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in"...
Vocera Introduces New Wearable Smartbadge Purpose-Built for Healthcare
January 8, 2019
(AETOS Wire)-- Vocera Communications, Inc. (NYSE:VCRA), a recognised leader in clinical communication and workflow solutions, today announced the launch of a new category of wearable communication devices that enables clinician agility and accelerates patient care. The Vocera Smartbadge combines smartphone usability with the hands-free freedom of the Vocera Badge to redefine healthcare communication – again. “Vocera"...
Factory CRO and Boston Biomedical Associates Announce Merger
January 8, 2019
(AETOS Wire) -- Factory-CRO Group, a leading global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs), and Boston Biomedical Associates (BBA) a premier full-service Medical Device/Biotechnology CRO and Consultancy based in the United States announce that they have merged the organizations. The merger further advances the shared strategic vision to become the leading Global Medical Device and Medical Technology focused CRO. Following the recent acquisitions of MileStone Research Organization, Five Corners, and Clinical Device Group the Factory-CRO Group now has specialized operations and expertise in the United States, Australia/New Zealand, and Europe. This global expansion coupled with the diverse medical therapeutic expertise provides a means to efficiently service clients. “BBA is excited to join Factory-CRO’s worldwide group as it will allow us to expand our comprehensive service offering to our clients,” said Lauren Baker, PhD, President and CEO of BBA. “The alignment of Factory-CRO and BBA’s......
Cambridge Epigenetix announces programme for routine screening and detection of colorectal cancer and other common tumours
January 8, 2019
(AETOS Wire) -- Cambridge Epigenetix Ltd, a pioneer in the development and application of epigenetic technologies, today announces its discovery and development programme for a test to detect colorectal and other cancers. This follows completion of a c. $30 million funding round, as well as the acquisition of exclusive patent rights for its epigenetic sequencing platform. Epigenetic changes act as a control"...
Sudan : Omar al-Bashir makes strategic change at the top of health department
January 7, 2019
NEWSROOM (ADV) – Sudanese President Omar al-Bashir on Saturday issued a decree to appoint new health minister, official SUNA news agency reported. Al-Khair Al-Nur Al-Mubarak was appointed Health Minister replacing Mohamed Abu Zaid Mustafa, SUNA said. The president also issued decisions to appoint Issam-Eddin Mohamed Abdalla as secretary-general of the National Council"...
GE Healthcare, Vanderbilt University Medical Center Partner for Safer, More Precise Immunotherapy Cancer Treatment
January 6, 2019
(AETOS Wire)-- GE Healthcare and Vanderbilt University Medical Center (VUMC) today announced a five-year partnership to enable safer and more precise cancer immunotherapies. Multiple diagnostic tools will be developed to help predict both the efficacy of an immunotherapy treatment and its adverse effects for a specific patient before the therapy is administered. This would allow physicians to better target immunotherapies to the right patients and avoid potentially damaging, ineffective"...
|
|
|
|
|